Search

Your search keyword '"Heparin, Low-Molecular-Weight chemical synthesis"' showing total 39 results

Search Constraints

Start Over You searched for: Descriptor "Heparin, Low-Molecular-Weight chemical synthesis" Remove constraint Descriptor: "Heparin, Low-Molecular-Weight chemical synthesis"
39 results on '"Heparin, Low-Molecular-Weight chemical synthesis"'

Search Results

1. The design and synthesis of new synthetic low-molecular-weight heparins.

2. Preparation and evaluation a new generation of low molecular weight heparin.

3. Preparation and optimization of N-trimethyl-O-carboxymethyl chitosan nanoparticles for delivery of low-molecular-weight heparin.

4. A latent reactive handle for functionalising heparin-like and LMWH deca- and dodecasaccharides.

5. Preparation and Characterization of Low Molecular Weight Heparin by Liquid Phase Plasma Method.

6. Oral delivery of a potent anti-angiogenic heparin conjugate by chemical conjugation and physical complexation using deoxycholic acid.

7. Homogeneous low-molecular-weight heparins with reversible anticoagulant activity.

8. Pharmacological effects and clinical applications of ultra low molecular weight heparins.

9. Proteoglycans and glycosaminoglycans in misfolded proteins formation in Alzheimer's disease.

10. Isolation of low-molecular-weight heparin/heparan sulfate from marine sources.

11. Ultrasonic-assisted preparation of a low molecular weight heparin (LMWH) with anticoagulant activity.

12. Preparation and application of a 'clickable' acceptor for enzymatic synthesis of heparin oligosaccharides.

13. Cyclic RGDyk-conjugated LMWH-taurocholate derivative as a targeting angiogenesis inhibitor.

14. Pharmacokinetics of a paclitaxel-loaded low molecular weight heparin-all-trans-retinoid acid conjugate ternary nanoparticulate drug delivery system.

15. Chemoenzymatic synthesis of the next generation of ultralow MW heparin therapeutics.

17. Chemoenzymatic synthesis of homogeneous ultralow molecular weight heparins.

18. Inhibitors of slit protein interactions with the heparan sulphate proteoglycan glypican-1: potential agents for the treatment of spinal cord injury.

19. Low-molecular-weight heparin from Cu2+ and Fe2+ Fenton type depolymerisation processes.

20. Production of heparin-containing hydrogels for modulating cell responses.

21. Low-molecular weight molluscan glycosaminoglycan from bivalve Katelysia opima (Gmelin).

22. Absorption study of deoxycholic acid-heparin conjugate as a new form of oral anti-coagulant.

23. Efficacy of orally active chemical conjugate of low molecular weight heparin and deoxycholic acid in rats, mice and monkeys.

24. Free radical generation during chemical depolymerization of heparin.

25. Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists.

26. Modulation of antithrombin-protease interactions by semisynthetic low-molecular-weight heparins with different sulfation patterns.

27. Effects of calcium ions on the interactions between antithrombin and factor Xa mediated by variously sulfated, semisynthetic low-molecular-weight heparins.

28. Preparation and characterization of 'heparinocytes': erythrocytes with covalently bound low molecular weight heparin.

29. An update on heparins at the beginning of the new millennium.

30. Development of tinzaparin: a heparinase-digested low-molecular-weight heparin.

31. Production and chemical processing of low molecular weight heparins.

32. Production method affects the pharmacokinetic and ex vivo biological properties of low molecular weight heparins.

33. Current trends in the development of anticoagulant and antithrombotic drugs.

34. Synthesis of a N'-alkylamine anticoagulant active low-molecular-mass heparin for radioactive and fluorescent labeling.

35. [The great Scandinavian Jahre Prize 1993. What is the function of heparan sulfate?].

36. Semisynthesis and analysis of lipophilically modified unfractionated and low molecular mass heparins.

37. Current perspectives on low molecular weight heparins.

38. Oligosaccharide mapping of low molecular weight heparins: structure and activity differences.

Catalog

Books, media, physical & digital resources